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Abstract  
Effect of bi-weekly supervised training sessions and prepared meals on the body weight and body 




Breast cancer is ranked the most common cancer among Canadian women, with statistics 
showing that 1 in 8 women will be diagnosed with breast cancer in her lifetime. While advanced 
treatments contribute to higher survival rates, the quality of life to which the breast cancer 
survivors live is negatively affected. The psychological and physical impact of breast cancer is a 
challenge during and after treatment, as treatment leave sequalae for breast cancer survivors 
including fatigue, fear of cancer recurrence, body image issue, depression, all of which lead to a 
sedentary lifestyle. A sedentary lifestyle is associated with weight gain, which contributes to 
accumulation of fat tissue. An excess amount of weight that contributes to a high body mass 
index greater or equal to 25 kg/m2 is associated with negative health outcomes including 
cardiovascular and metabolic diseases and co-morbidities. Particularly in breast cancer survivors, 
fat tissue contains properties that produce estrogen, a hormone that promotes the development of 
breast cancer, hence increasing the risk of recurrence of breast cancer. The inflammatory 
properties of fat tissue also promote the development of breast cancer. Therefore, while the 
survival rates of breast cancer increase, emphasis to the management of body weight should be 
addressed. The combination of physical activity and healthy nutrition is widely known to manage 
body weight in breast cancer survivors. However, the level physical activity achieved by breast 
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Breast cancer is the most common cancer occurring in women around the world, making 
up 25% of the new cases of cancer yearly (Government of Canada, 2019).  While the majority of 
breast cancer patients are females, breast cancer can also occur in males. One woman out of eight 
is likely to develop breast cancer, with an estimated 26,300 new cases of breast cancer, and 5,000 
will not survive due to development of metastases, at which point the cancer is advanced and not 
curable (Government of Canada, 2019). Early breast cancer diagnosis and advanced effective 
treatments may contribute to the increased survival rate of breast cancer. While the survival rate 
increases, breast cancer survivors are more likely to live with consequences from the treatments, 
making breast cancer one of the most significant health problems. 
The breast tissue extends from the axilla to the sternum, making the mammary glands 
which is composed of fat cells and lobules. A network of ducts within the mammary gland carries 
milk from the lobules to the nipple. Breast cancer is a result of abnormal cell growth, which 
originally starts within the cells of the mammary gland and spreads through the regional lymph 
nodes, bloodstream, or both. Breast cancer comprises two types: carcinoma in situ or invasive 
cancer. Carcinoma in situ consists of cancer cells that spread within ducts, also called ductal 
carcinoma, or lobules, also called lobular carcinoma, but both types of carcinoma do not extend 
to the stromal tissue of the breast (Akram et al., 2017). Ductal carcinoma consists of cancer cells 
starting from the ducts and is detected only by mammography. It comprises 90% of all in situ 
breast carcinomas and 70% of all invasive breast carcinomas (Snoj et al., 2010). Lobular 
carcinoma in situ consists of cancer cells beginning from the lobules and can be multifocal and 
bilateral (Inoue et al., 2017). Invasive breast carcinomas refer to cancer spreading to other tissues, 
commonly the liver, the bones, and the lungs (Ma et al., 2015).  
Knowing the cause of breast cancer helps doctors treat the cancer more efficiently. An 
estrogen-receptor positive tumor and progesterone-receptor positive mean that the estrogen and 
progesterone hormones bind to their respective receptors within the breast cancer, which promote 
the modification of DNA and cell division (Lange & Yee, 2008). The human epidermal growth 
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factor receptor 2 (HER2) controls the growth of protein on the surface of the breast cells (Iqbal & 
Iqbal, 2014). However, a tumor may develop as the HER2 is overexpressed and there are too 
many copies of this gene (Iqbal & Iqbal, 2014).  
Risk factors 
Age and sex are risk factors for breast cancer. Women are more likely to develop breast 
cancer compared to men. In Canada, 83% of the women diagnosed with breast cancer are over 50 
years of age (Government of Canada, 2019). 
Estrogen is a hormone produced by the ovaries in the first half of the menstrual cycle. 
Estrogen is in the forms of estradiol before menopause, estriol during menopause, or estrone after 
menopause (Elder & Thacker, 2016). Estrogens can bind to the estrogen receptors in the breast 
cells to stimulate the growth of milk ducts in the breasts (Brisken & O’Malley, 2010). Estrogen 
exposure influences the development of breast cancer. The lifetime exposure of estrogen is 
longest as women starts the menarche at a younger age, reaches menopause at a later age, or 
increases adipose tissue, or a combination of the factors (Dall & Britt, 2017).  In hormone 
receptor-positive breast cancer, the estrogen receptor stimulates the growth of the breast cell in an 
uncontrolled way (Lange & Yee, 2008).  
Genetic factors influence the mutation in breast cancer type 1 (BRCA1) and type 2 
(BRCA2). BRCA1 and BRCA2 are proteins that repairs damaged DNA (Mehrgou & 
Akouchekian, 2016). Inherited mutations in BRCA1 and BRCA2 affect the normal functions of 
the genes, and additional genetic alterations can develop several types of cancer, notably breast 
cancer in female (Mehrgou & Akouchekian, 2016). Parents who carry mutated BRCA1 or 
BRCA2 increase the child’s risk of carrying the genes by 50% (National Cancer Institute, 2018).  
Weight gain occurring during early adulthood, midlife, and during menopause increases 
the risk of postmenopausal breast cancer (Alsaker et al., 2013). According to a population-based 
case control study of breast cancer, each additional five kilograms of body weight gain during 
adulthood is associated with an increased risk of 4% of breast cancer in postmenopausal women 
(Han et al., 2006).  Being overweight or obese increases the risk of developing breast cancer. A 
study demonstrated that a body mass index (BMI) greater than 24.9 kg/m2 increases the risk of 
postmenopausal breast cancer by 1.5 to 2 times (Ligibel et al., 2019). In particular, 
postmenopausal women with excess amount of body fat are more likely to develop estrogen 
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receptor-positive and progesterone receptor-positive breast cancers, in addition to advanced 
disease and death, as the adipose tissue is the main site to produce estrogen after menopause 
(Neuhouser et al., 2015). Women with obesity are prone to produce estrone and estradiol two 
times more than women without obesity (Warren et al., 2015).     
The adipose tissue contains properties that produce hormones that contributes to the 
development of cancer. The adipose tissue converts androstenedione to estrone, a weak form of 
estrogen (Dieli-Conwright et al., 2018). An abnormal increase of estrogen level may lead to 
growth of tumor (Siiteri, 1987). The adipose tissue also stimulates the synthesis of aldosterone, 
which affects the activity the adrenal gland (Siiteri, 1987). Stimulation of the adrenal secretory 
activity produces precursors of androgen, which has the ability to increase level of estrogen in the 
peripheral tissues (Siiteri, 1987). The adipose tissue may also contribute to increase inflammation 
as it has properties to produce pro-inflammatory cytokines, including interleukin-6 (IL-6) and 
tumor necrosis factor (TNF) which stimulate chemokines that attract neutrophils (Dinarello, 
2006). Neutrophils are white blood cells that promote the progression of cancer and metastasis 
(Wu et al., 2019).  
Signs and symptoms before and after breast cancer  
Identifying the signs and symptoms of breast cancer is important because an early 
detection of breast cancer is key to improve treatment outcomes. Signs and symptoms of the 
development of breast cancer include the appearance of lump in the breast or the axilla, changes 
in the shape or size of the breast or the nipple, and abnormal discharge from the nipple.  
The treatments of breast cancer often leave side effects that may affect the quality of life 
of the breast cancer survivors. Chronic fatigue commonly occurs after treatment of several types 
of cancer, including breast cancer (Morrow et al., 2002). Cancer-related fatigue differs from 
general fatigue, as it is not proportionally related with the level of exertion and is not alleviated 
by sleep or rest (Morrow et al., 2002). Cancer-related fatigue lasts for a longer duration and 
higher degree of severity, affecting the capacity to work and to engage in social activity. Fatigue 
in breast cancer occurs as early as the initiation of treatment, including surgery, radiation, and 
chemotherapy, and fatigue may last for up to ten years post-treatment (Bower et al., 2006).  
Weight gain associated with chemotherapy is commonly experienced by the majority of 
patients. The Women’s Healthy Eating and Living study states that women who underwent 
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chemotherapy have a 65% greater chance of gaining weight, which could be attributed to being 
sedentary (Pierce et al., 2007).  
Breast cancer-related lymphedema (BCRL) is a common symptom that occurs in women 
following cancer treatment, with the incidence ranging from 5% to 56% (Ozaslan & Kuru, 2004). 
The wide range is due to having no standard guidelines for diagnosing lymphedema. 
Lymphedema is a chronic symptom that can occur within three years of breast cancer treatment 
(Norman et al., 2009). The type of treatment received and the number of nodes removed may 
correlate with the risk of developing lymphedema. The incidence of BCRL ranges from 10-56% 
in women who undergo axillary lymph node dissection, a method that consists of extracting on 
average 10-20 lymph nodes in the armpit to detect the presence of cancer (Kwan, 2010). The 
incidence of BCRL is less in women who undergo sentinel lymph node biopsy, with a range of 
incidence between 0-23% (Kwan, 2010).  
Treatment of breast cancer  
           Several forms of treatment have side effects that affect the quality of life of breast cancer 
survivors. Surgery, radiotherapy, and systemic therapy are different treatments that can be used 
separately or in combination to treat breast cancer.  
Surgery is commonly the primary treatment of breast cancer. Patients undergoing a 
lumpectomy have a partial portion of the breast removed. A mastectomy consists of removing the 
complete breast and depending on what type of mastectomy the patients are undergoing; the 
muscle and the lymph nodes may be affected. Axillary lymph node dissection consists of 
removing the lymph nodes located in the axilla. Depending on the severity of the breast cancer, 
the removal of lymph nodes can vary between one to ten or more. Sentinel lymph node biopsy is 
a less invasive surgery that consists of removing the first lymph node that filters the fluid 
containing the breast cancer away from the breast tissue. McLaughlin et al. (2008) reported that 
although there is still a clinical risk of lymphedema, breast cancer patients who undergo sentinel 
lymph node biopsy are less likely to develop lymphedema five years post-treatment compared to 
those who undergo sentinel lymph node biopsy followed by axillary lymph node dissection. The 
removal of lymph nodes disrupts the axillary lymphatic system by obstructing the drainage 
channels, which impede the extraction of the lymph fluid out of the affected area (Campbell & 
McTiernan, 2007). This causes the protein, cells, and fat to remain in the interstitium (Campbell 
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& McTiernan, 2007).  Eventually, the amount of protein present in the subcutaneous tissue in the 
arm will increase, causing inflammation in the limb (Campbell & McTiernan, 2007).  As a result 
of the infection, the tissue becomes less distensible and the weight of the arm increases 
(Campbell & McTiernan, 2007).  The subcutaneous and lymph vessel eventually become fibrotic 
as a result of the inflammation (Campbell & McTiernan, 2007). Larson et al. (1986) reported the 
risk of lymphedema development is correlated with the amount of lymph nodes removed. The 
authors reviewed the records of 475 women with early breast cancer who received axillary 
irradiation. Of the 475 patients, 240 underwent axillary surgery and the risk of lymphedema is 
37% for the patients who had full dissection compared to 8% for the patients how had partial 
axillary lymph node dissection (Larson, 1986). The risk of lymphedema six years post-treatment 
was 28% when more than ten nodes were dissected; whereas, the incidence drops to 9% when 
less than ten nodes were dissected (Larson, 1986).  
There is no standard definition for breast cancer-related lymphedema. The criteria that is 
the most commonly used is a difference of at least 200 milliliters of volume between the affected 
and the unaffected arm (Yang et al., 2018). On the other hand, a difference in circumference of at 
least two centimeters between the affected and unaffected arm can also indicate the presence of 
lymphedema (Armer & Stewart, 2005). Lymphedema could occur on the hands, arms, shoulders, 
legs, trunk, head, or neck. Since the surgery for breast cancer occurs on one side of the upper 
body, the inflammation mostly occurs on the arm of the affected side.  
Tamoxifen is a common medication prescribed during treatment and as a preventative 
option of breast cancer after the treatment to reduce the recurrence of breast cancer. Tamoxifen 
inhibits the action of estrogen which reduces the incidence of breast cancer by 50-75% 
(Cummings et al., 2000). Weight gain is commonly recognized as a side effect of tamoxifen, 
especially during the first 12 months of treatment (Sestak et al., 2012). Although weight gain is 
often reported by women taking tamoxifen or anastrozole after the cancer is cured, a clinical trial 
reported no independent effect of tamoxifen or anastrozole on weight change (Sestak et al., 
2012).  
Physical activity and breast cancer  
Physical activity is widely known for its positive outcomes in different type of population, 
including breast cancer survivors.  Treatment of breast cancer leave side effects that negatively 
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affect the quality of life of breast cancer survivors due to several signs and symptoms including 
chronic fatigue, weight gain, depression, and sleep disturbances. Risk of cancer is associated with 
a sedentary lifestyle due to different mechanisms including a higher insulin-resistance and C-
reactive protein systemic inflammation and weakening of the function of the immune system by 
not stimulating the t-helper cells (Campbell & McTiernan, 2007). Several studies demonstrate 
promising benefits of physical exercise in breast cancer survivors similar to general apparently 
healthy population such as improved immune function, energy level, cardiopulmonary function, 
moon, and quality of life. Physical activity reduces the risk of developing new case of breast 
cancer, breast cancer recurrence, and increase the survival rate. 
Different mechanisms may explain the role the protective effect of physical activity. 
Physical activity decreases level of estradiol in premenopausal women and decreases level of 
estrone in postmenopausal women, both of which reduce the risk of breast cancer development 
(Cleary & Grossmann, 2009). As the adipose tissue is the main source of estrogen production in 
postmenopausal women, increased amount of physical activity reduces level of adipose tissue, 
which reduces the risk of the development of breast cancer by reducing the amount of production 
of estrogen (Cleary & Grossmann, 2009).  
Insulin and IGF-1 are both factors that promote the development of breast cancer, as they 
have properties that stimulate the activity of estrogen synthase, and therefore increase level of 
estrogen (Meneses-Echávez et al., 2016). Insulin and IGF-1 also decreases the secretion of sex 
hormone-binding globulin from the liver, which is a steroid-binding plasma glycoprotein that 
inhibits the production of estrogen. Exercise reduces the level of insulin and IGF-1, which is 
beneficial in reducing the level of estrogen in the body (Meneses-Echávez et al., 2016).  
Increasing the level of physical activity also helps with management of body weight and 
improve the body composition. As stated earlier, the adipose tissue becomes the main site for the 
production of estrogen after menopause, and increasing the level of physical activity will reduce 
the amount of adipose tissue, hence less production of estrogen. A study demonstrated that after a 
16-week of supervised training sessions that included aerobic and resistance training three times 
per week, obese postmenopausal breast cancer survivors experienced a significant improvement 
in body composition and systematic inflammation, with a significant decrease in adipose tissue 
and increase secretion of anti-inflammatory cytokines (Dieli-Conwright et al., 2018).  
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A 6-month weight training intervention in which breast cancer survivors were supervised 
in groups of four participants by qualified exercise professionals twice per week for 13 weeks 
demonstrated an improvement in physical and psychosocial quality of life through an increase in 
lean muscle mass and increase in upper body strength (Ohira et al., 2006). 
Nutrition and breast cancer  
The National Cancer Institute recommends a dietary change for breast cancer survivors, 
by consuming a diet high in fruits and vegetables, high in whole grains, and low in fat (National 
Cancer Institute, 2018). The dietary guideline aims to prevent the recurrence of cancer. Studies 
show a diet containing high amount of omega-3 fatty acids, as much as three times more than the 
recommendation for healthy individuals, is beneficial as this nutrient contains potential 
anticarcinogenic compounds and chemical properties that inhibit the growth of breast tumors and 
induce death of breast cancer cells (Fabian et al., 2015; Rovito et al., 2015). Sources of omega-3 
fatty acids include fish such as salmon, canned tuna, white fish, as well as olive oil. Lignan is a 
nutrient with properties that are anticarcinogenic and that alters the metabolism of estrogen in the 
body. Lignan are phytoestrogens with chemical structure that are similar to an estrogen molecule 
(Calado et al., 2018). Lignan can decrease cell growth located in the breast tissue and prevents 
cell proliferation by enhancing apoptosis (McCann et al., 2010).  Lignan is found mainly in 
flaxseeds, but also in soy, whole grains, and some fruits such as peaches (Murkies et al., 1998). 
Dietary fibers contain properties capable of decreasing the level of estrogen in the circulating 
blood. Higher intake of dietary fiber reduces the risk of breast cancer, in particular 
postmenopausal women (Pierce et al., 2007). Canadian women are not meeting the recommended 
intake of omega-3, lignan, and dietary fibers, which is a concern as breast cancer is the most 
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Chapter II  
Effect of bi-weekly supervised training sessions and prepared meals on the body weight and 
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Abstract  
Introduction: Lifestyle intervention targeted for breast cancer survivors is important as the 
treatments for breast cancer leave sequelae affecting their quality of life.  Weight gain is a 
common side effect after the treatment of breast cancer and presents with physiological factors 
that may contribute to the recurrence of breast cancer. The aim of this pilot study is to evaluate 
the effect of supervised training sessions and dietary interventions on the body weight and 
volume of the arm of breast cancer survivors.  
Methods: Nineteen women were recruited, including 11 with breast cancer-related lymphedema 
(BCRL). Participants received prepared breakfast and lunch meals (total calories = 717 kcals) for 
5 days per week over the 12-week period. The participants followed an exercise program, 
supervised by kinesiologists twice a week, one hour each session for 10 weeks. The participants 
continued with the same exercise program without supervision for an additional 12 weeks. Body 
weight and arm volume were obtained at baseline and at week 10.  
Results: The primary outcome measures were body weight and arm volume. The preliminary 
results showed a significant reduction in body weight (p=0.007), body mass index (p=0.007), and 
arm volume of the surgical side (p=0.003) and the non-surgical side (p=0.001) after 10 weeks of 
intervention.  
Conclusion: These preliminary results indicate that 10 weeks of supervised training sessions and 
dietary intervention may be an effective strategy to reduce body weight in breast cancer survivors 
and arm volume in women with BCRL.  
 
Key words: Breast cancer, lymphedema, exercise, diet  
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Introduction 
 While the number of breast cancer survivors rises as a result of early detection and 
advanced efficient treatment options, these women may experience living longer with the 
negative side effects from the treatments of breast cancer, including weight gain, lymphedema, 
poor quality of life, and chronic fatigue. Care for breast cancer survivors is important and 
supports the need for promoting a healthier lifestyle behaviour.  
 Fatigue is the most common symptom experienced after the treatment of breast cancer 
which negatively affects the level of physical activity of breast cancer survivors (Meeske et al., 
2007). Fatigue also contributes to a sedentary lifestyle and weight gain. Body mass index (BMI) 
is an indicator of health risk.  As BMI increases above 24.9 kg/m2, there is an increased risk of 
developing cardiovascular disease, metabolic disease, and co-morbidities.  Weight gain occurs in 
50-96% of women during treatment of breast cancer, which commonly happens in 
premenopausal women receiving adjuvant chemotherapy (Freedman et al., 2004). Weight gain 
occurs at a faster rate in breast cancer survivors during the first five years after cancer treatment, 
in particular after chemotherapy (Gross et al., 2015). The risk increases proportionally with the 
duration of the treatment and with the presence of obesity (Dignam, 2003). The association 
between obesity and breast cancer especially in postmenopausal women may also be related to 
estrogen activity as this hormone is strongly linked to an increase in breast cancer risk (Dignam, 
2003).  
Increase of fat tissue and decrease in lean tissue results in reduced metabolic activity, 
hence less calories expended.  In particular, fat deposit around the visceral organs, also known as 
visceral fat, is reflected by the circumference of the waist. A greater visceral fat is associated with 
negative health risk. A reduction of waist circumference is linked with a lower risk of obesity-
related cancer risk (Luo et al., 2019).  
In addition to weight gain that occurs during and after the treatment of breast cancer, 
lymphedema is a common side effect that may occur within the first three years post-treatment, 
with the risk ranging from 5% to 56% (Ozaslan & Kuru, 2004). The large range is due to the lack 
of standardized diagnosis of lymphedema. Breast cancer-related lymphedema (BCRL) is the 
inflammation of the lymph and occurs generally due to treatment of breast cancer that disrupts 
the lymphatic system, particularly around the axillary nodes. While several studies demonstrated 
that obesity increase the risk of BCRL, some also report that lymphedema may also lead to 
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obesity, suggesting a reciprocal relationship between obesity and lymphedema (Mehrara & 
Greene, 2014). The excess of body weight may increase the risk of developing BCRL, with the 
severity of lymphedema being positively correlated with the degree of obesity (Fabian et al., 
2015).  A prospective study shows that women with breast cancer and BMI greater than 30 are 
three times more likely to develop lymphedema compared with women with breast cancer and 
BMI less than 25 (Helyer et al., 2010). An impaired lymphatic function can develop excess 
adipose deposition and obesity (Mehrara & Greene, 2014). Women who are affected by 
lymphedema experience signs and symptoms on the affected arm, including a larger arm 
circumference, heavier arm on the affected side, pain, discomfort, limited range of motion, in 
addition to psychosocial consequences such as body image disturbance and decreased quality of 
life, all of which being a barrier to become physically active (Norman et al., 2009).  As the 
lymphedema develops, it becomes irreversible once it reaches the second stage. To date, there are 
no known cures for lymphedema; therefore, special care is critical to manage the signs and 
symptoms. It was previously believed that exercise is contraindicated in women affected by 
lymphedema. Recent studies demonstrated positive outcomes with regular training sessions at 
low, moderate, and high intensity, including a better quality of life (Wanchai & Armer, 2019). 
As women are more likely to gain weight after the treatment of breast cancer, a healthy 
nutrition is important to manage body weight and to decrease adverse health risks. In addition to 
a reduced metabolic activity post-treatment, a caloric imbalance with the energy intake being 
greater than the energy expenditure results in weight gain. Breast cancer survivors are advised to 
modify their nutritional habits to meet their daily nutrition needs including a higher amount of 
omega-3 intake, that is three times more than the daily recommendation for healthy individuals, 
and higher amount of fiber intake (Fabian et al., 2015). The recommendations are accommodated 
such to reduce the risk of recurrence of cancer and to decrease the inflammation.  
Reaching the minimum recommendation of 150 minutes of physical activity at moderate 
to vigorous intensity, as recommended by the Canadian Society of Exercise Physiology (CSEP), 
may not be feasible for women after the treatment of breast cancer. Several barriers affecting the 
physical activity level of breast cancer survivors include diminished level of confidence, chronic 
fatigue, and limited ability to move caused by the signs and symptoms post-treatment (Bower, 
2014). A cohort study reported that among the 32% of 806 breast cancer survivors who met the 
physical activity recommendation, a small portion of participants had BMI in the obese category 
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(Irwin et al., 2010). Nonetheless, the CSEP guideline reports some health benefits and improved 
functional abilities even if the amount of physical activity is below the recommended levels, 
providing the volume of exercise gradually increases until the guideline is met.  
Knowing that breast cancer survivors are more likely going to continue to live with the 
side-effects from the treatment, reducing the weight is a strategy to decrease the risk of cancer 
recurrence as well as the signs and symptoms related with cancer. To our knowledge, no studies 
involving weight loss in breast cancer include a rigorous method whereby participants are closely 
monitored in both exercise and nutrition. The purpose of this pilot study is to evaluate the 
feasibility of a 22-week intervention combining supervised training sessions and prepared meals 
and its effect on the body weight and body composition of the breast cancer survivors. We 
hypothesized that the combination of exercise and dietary intervention would generate a clinical 
meaningful reduction in body weight by 5-7%. We also hypothesized that the combination of 
exercise and dietary intervention would significantly decrease the volume of the affected arm of 
the women with BCRL. The present article reports the preliminary results that reflects the 
changes over the first 10 weeks period that includes the supervised training sessions and the 
prepared meals intervention.    
  13 
Methods  
Study design and participants 
  Study Design: This prospective study was a single group, pre-post test, quasi-
experimental pilot.  Approval to conduct the study was provided by the Human Research Ethics 
Committee of Concordia University. The participants were recruited from the Lymphedema 
Clinic at the McGill Nutrition and Performance Laboratory (MNUPAL) and from the PERFORM 
Centre affiliated with Concordia University in Montreal. A total of 19 female breast cancer 
survivors were recruited, of which 11 have breast cancer-related lymphedema. The inclusion 
criteria were that they must be above 18 years old; body mass index greater than or equal to 25 
kg/m2; participating in less than 60 minutes of vigorous physical activity per week; has no 
recurrent cancer; has no bilateral lymphedema. The exclusion criteria were that they must not 
have a diagnosis of uncontrolled heart disease, hypertension and diabetes; has bilateral 
lymphedema; has recurrent cancer; still undergoing treatment for cancer; following a 
personalised diet.  
 Flyers describing the purpose of the study were posted in the waiting area of the 
Lymphedema clinic and inside the consultation room. The doctor specialized for the lymphedema 
sent personal e-mail to physiotherapists and kinesiologists about the study to refer patients to the 
study. The researcher went regularly at a frequency of once per week to meet with potential 
participants who may be eligible to participate in the study. Flyers were posted on the wall and on 
the television screen on the conditioning floor at PERFORM Centre. The participants were 
contacted by e-mail, by phone, and in person by the researcher to confirm the eligibility criteria.  
Two orientation sessions were hosted to gather all potential participants in one room at 
PERFORM Centre, where the researcher explained in detail the study. Recruitment took place 
between October 2018 to September 2019.  Prior to recruitment, all participants signed a written 
informed consent. While all participants were aware of the purpose of the study, all participants 
were blinded from the data obtained until the participants completed the study. All interested 
participants were asked to complete forms and questionnaires, including the informed consent, 
the adult medical history form, the waiver form, and the Physical Activity Readiness 
Questionnaire (PAR-Q+). After completion of the forms and confirmation of study enrollment, 
the clinical exercise physiologist and the dietician proceeded with booking the appointments for 
the fitness assessment and for the nutrition counselling.  
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Protocols  
The participants followed a progressive training program twice per week for 22 weeks 
which included aerobic, resistance, and stretch exercises (Appendix A). All women with BCRL 
were advised to wear compression garments while exercising. Certified exercise professionals 
and interns from the Health, Kinesiology and Applied Physiology program specialized in Clinical 
Exercise Physiology of Concordia University supervised the first 10 weeks of bi-weekly training 
sessions of each participants. The participants were followed individually by the certified 
exercise professionals and the interns. The role of the certified exercise professionals and the 
interns served to ensure a safe training session while monitoring exercise progression. The 
participants continued to follow the training program for the remaining 12 weeks, with self-
progression.  Adjustments to the training program were made on individual basis based on the 
perceived exertion of the participants. All participants with BCRL (n=11) were advised to wear a 
compression sleeves during the training sessions.  
The training sessions were monitored using a SmartKey which uses the TechnoGym 
program. The participants were instructed on the usage of the SmartKey.  
Nutrition counselling including the 24-hour recall was done by the dietician at baseline, at 
10 weeks, and at 22 weeks. The dietician also provided dietary advice for each participant, with 
the goal to reduce daily caloric intake by 500 kilocalories per day in order to achieve a healthy 
body weight reduction of one to two pounds per week.  
Participants were asked to collect two sets of food bags once a week for 12 weeks 
(Appendix B). Each pair of bags contained 10 meals including breakfast and lunch, with both 
meals contributing to 717 kilocalories on average  (Appendix C). Each participant was expected 
to consume the 10 meals in one week. The dinner was not included in the meal bags. The 
participants were responsible for the remaining dinner meal to complete their daily food intake, 
keeping in mind their daily recommended needs that was discussed during their nutrition 
counselling.  
Three cooking classes were offered after 12 weeks of the study.  Each cooking class had a 
different theme to promote healthier eating behaviour, namely “Lower salt and sugar contents in 
the meals”, “The importance of Omega-3”, and “Cooking vegan meals”. Each participant was 
invited to assist in two of the three cooking classes. At the end of each cooking class, the 
participants took the food home.  
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After completion of the study, each participant was contacted by phone for an exit survey 
of approximately 45 minutes. The interview was audio-recorded on the phone and the women 
discussed about their opinion and thoughts of participating in the study, and how it changed or 
did not change their daily routines.  
Study outcomes 
All assessments were taken at PERFORM Centre in the Kinesiology Clinic. We assessed 
the participants at baseline, at 10-weeks, and at 22-weeks. All participants fasted and avoided 
strenuous physical activity at least 6 hours prior to each assessment. The primary outcomes were 
changes in body weight and volume of the arm.  
Anthropometric measurements  
Resting heart rate was measured manually by locating the radial nerve of the participant. 
The number of beats per minute was obtained by multiplying the number of pulses in 15 seconds 
by four. Resting blood pressure was measured manually using the sphygmomanometer and 
stethoscope.  
Height was measured using the stadiometer. The tester asked the participant to remove 
shoes, to stand with the heel, buttocks, upper back, and head in contact with the stadiometer, with 
feet together. The height measurement was obtained as the participants inhale. The height 
measurement was recorded to the nearest 0.5 centimeters.  
The body weight was measured using an electronic body weight scale. The participants 
were asked to remove shoes and to stand on the scale. The weight measurement was recorded to 
the nearest 0.1 kilograms.  
Circumference of the waist was measured using a tape measurement, which was wrapped 
around the waist of the participant, at the level of the superior edge of the iliac crest.  The 
circumference of the waist was recorded to the nearest 0.5 centimeters.  
The circumference of the hip was measured using a tape measurement, which was 
wrapped around the maximal extension of the buttocks. The circumference of the hip was 
recorded to the nearest 0.5 centimeters.  
The body composition was measured using the ImpediMed SFB7, which provided 
information about the total body water content, the extracellular fluid, the intracellular fluid, the 
fat mass, and the fat free mass. The bioimpedance unit was calibrated prior to each measurement 
performed. The participants were lying supine on a massage bed. Prior to taking the 
  16 
measurements, the participants rested for five minutes. During the five minutes of rest, the tester 
applied four electrodes on the right side of the body; the first electrode was placed on the wrist at 
the level of the ulnar styloid process, the second electrode was placed five centimeters apart from 
the first electrode, the third electrodes was placed on the ankle at the level of the medial and 
lateral malleolus, and the fourth electrode was placed five centimeters apart from the third 
electrode.  
The volume of the arm was measured using the circumferential tape method, adapted by 
the Lymphedema Clinic at the MNUPAL. The measurements were taken without comparing 
previous measurements from prior visit to reduce bias. The participants were seated on a chair, 
with both arms extended and pronated against a pillow on the thigh. The tester measured the 
circumference of the palm, the wrist, the forearm, the elbow, the midarm, and the axilla. The 
measurements of each circumferences were included in the truncated cone equation to obtain the 
volume of the different segment of the arms. The volume of the arm was obtained by summing 
each volume of the segment of the arm.  
Balance 
 The unipedal stance test was performed to assess the static balance. The test protocol was 
adapted from the CSEP-PATH. The participants stand barefoot on one leg with arms crossed 
over the chest while focusing on a marker at eye level for a maximum 45 seconds. The time stops 
if the participants uncross arms, touches the floor with the opposite foot, rotate the weight-
bearing foot on the floor, or reach 45 seconds. The participants then switch leg and repeat the 
same procedure. The participants will perform the same test with eyes closed. 
Muscular strength and endurance  
A hand dynamometer was used to assess the handgrip strength, adapted by the CSEP-
PATH protocol. Two trials were performed per side and the best score of each side was summed 
to obtain the total handgrip strength.  
The upper body strength was assessed using the 10-repetitions maximum (10-RM) Smith 
machine bench press. The participants were asked to lift the assigned weight for 10 repetitions 
until they reach their 10-RM. All participants were allowed to perform a maximum of five trials.  
The lower body strength was assessed using the 10-RM leg press. The participants were 
asked to lift the assigned weight for 10 repetitions until they reach their 10-RM. All participants 
were allowed to perform a maximum of five trials.  
  17 
The upper body endurance was assessed using the 30 seconds arm curls with a five 
pounds dumbbell and the 30 seconds single arm cable triceps pushdown with two and a half 
pounds. The participants were asked to perform as many repetitions as possible during the 30 
seconds in a safe and correct manner.  
Flexibility 
 The flexibility of the lower leg was assessed using the chair sit-and-reach test adapted 
from the senior fitness test. The measurements were recorded in inches for each side. The 
participants were seated on a chair. The participants were asked to have one leg extended at the 
knee with the toes pointing to the ceiling while the opposite leg is relaxed with the knees bent at 
90 degrees. The scoring leg is the leg that is extended. While keeping the spine neutral, the 
participants had two hands on top of the other. The participants were asked to take an inhale 
before exhaling and bending at the level of the hip to bring the hands with arms extended towards 
the toes. The distance was measured from the tip of the middle finger to the toes. If the fingers of 
the participants reached past the toes, the score is positive. If the fingers of the participants are 
behind the toes, the score is negative.  
Nutrition 
The food was prepared in the metabolic kitchen of the PERFORM Centre by the dietitian 
and students from the Human Nutrition program at the McGill University. The students were 
trained with sanitary procedures and cooked fresh produces that were delivered to PERFORM 
Centre every week. All baked and cooked foods were kept in the freezer while all fresh produce 
was kept in the fridge until they were provided to the participants. Women who had restrictions 
or allergies to certain food were provided with an alternative option with equivalent nutrient 
content. The 24-hour dietary recall was used by the registered dietician at baseline, at week-10, 
and at week-22 to record all foods and beverages consumed in the past 24 hours.  
Statistical analysis 
Due to a small sample size and to a lack of control group, all the variables were compared 
using the Student T Test to look at the differences from baseline to week 10 of the intervention. 
The normal distribution was statistically tested using the Shapiro-Wilk statistics. All variables are 
normally distributed except for weight, BMI, arm volume of the surgical side, arm volume of the 
non-surgical side, fat mass, and chest press. For those variables, the Wilcoxon-test was used for 
comparisons. The Pearson correlation test was used to analyse the correlation between body 
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weight and the volume of the surgical arm volume of the participants with BCRL, as those 
variables were shown to be normally distributed according to the Shapiro-Wilk statistics. The 
effect size was measured by dividing the mean difference of two groups over the average 
standard deviation. An effect size ranging from 0.2 to 0.5 is classified as small, 0.5 to 0.79 is 
classified as medium and an effect greater than 0.8 is large (Sullivan & Feinn, 2012).  
Results 
We approached 35 women with a history of breast cancer and we recruited 21 eligible 
participants. We refused a woman who had bilateral lymphedema (n=1), women with a BMI 
lower than 25 kg/m2 (n=2); women with a diet restriction, either they are vegetarian (n=1) or eat 
kosher food only (n=2). Although interested, some women did not want to participate in the study 
because some women would not want to travel to the research centre due to distance (n=5), some 
women had family or holiday commitments over the study period (n=2), and one woman who did 
not think she could add a new routine due to her full-time job (n=1). The baseline characteristics 
of the participants recruited are presented in Table 1.  
        
Table 1: Baseline characteristics of the breast cancer survivors  







    Mean  SD  Mean SD Mean  SD  
Age 
 
62 8 62 8 63 9 
Breast cancer diagnosis 2008 10 2009 9 2007 10 
Side of surgery        
 
Left 7  4  4  
 
Right  10  6  3  
 
Both 2  1  1  
Treatment of cancer       
 
Chemotherapy 15  10  5  
 
Radiotherapy 15  10  5  
Treatment during the study        
 
Tamoxifen 1  1    




4  3  1  
Lymphedema onset    2010 9   
 
Left   5    
 
Right    6    
BMI (kg/m2) 33.6 6.9 35.2 6.5 31.4 7.2 
 
Overweight 8  2  6  
 
Obese  4  4  0  
 
Severely obese  4  3  1  
 
Morbidly obese 3  2  1  
Weight (kg) 87.6 19.6 91.5 19.7 82.1 19.4 
Waist circumference (cm) 107.7 11.0 106.3 9.0 104.6 13.2 
Absolute fat mass (kg) 36.0 11.9 38.6 13.1 32.5 9.7 
Absolute fat free mass (kg) 52.1 8.7 53.9 7.2 49.7 10.4 
Relative fat mass (%) 40.0 5.1 40.7 5.7 39.1 4.2 
Relative fat free mass (%) 60.0 5.1 59.3 5.7 60.8 4.2 
 
 
Nineteen participants completed the 10-week exercise and dietary-intervention. Two 
participants did not complete the 10-week period of the study because of the complications with 
transport and one woman had a car accident and suffered back pain.  The preliminary results of 
the 10-week intervention are presented in Table 2 and Table 3.  












Anthropometric measurement       
Resting heart rate (bpm) 69 73 4 7.91 0.032* 
Systolic Blood Pressure (mmHg) 128 117 -11 12.07 0.001* 
Diastolic Blood Pressure (mmHg) 73 70 -3 8.61 0.071** 
Body Mass Index (kg/m2) 33.6 32.7 -0.9 1.24 0.007*‡ 
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Body weight (kg) 87.6 85.2 -2.4 3.34 0.007*‡ 
Waist circumference (cm) 107.7 103.2 -4.5 4.33 0.001* 
Hip circumference (cm) 118.9 115.8 -3.1 5.58 0.010*‡ 
Volume of the SA (mL) 2897.5 2698.0 -199.5 243.59 0.003*‡ 
Volume of the NSA (mL) 2651.8 2455.6 -196.2 211.47 0.001*‡ 
Body composition       
Total body water (L) 38.2 37.2 -1.0 1.82 0.028* 
Total body water (%) 43.9 43.8 -0.1 1.34 0.868 
Extracellular fluid (L) 16.2 15.9 -0.3 0.68 0.060** 
Extracellular fluid (%) 42.6 43.0 0.4 0.71 0.055** 
Intracellular fluid (L) 21.9 21.2 -0.7 1.22 0.027* 
Intracellular fluid (%) 57.4 57.1 -0.3 0.80 0.169 
Fat mass (kg) 36.0 35.1 -0.9 2.18 0.126‡ 
Fat mass (%) 40.0 40.1 0.1 1.82 0.910 
Fat free mass (kg) 52.1 50.7 -1.4 2.55 0.027* 
Fat free mass (%) 60.0 59.7 -0.3 1.97 0.660 
Musuclar strength and endurance       
Handgrip strength (kg) 44 47 3 8.54 0.253 
Leg press 10RM (lbs) 128 158 30 41.23 0.005* 
Chest press 10RM (lbs) 33 38 5 6.01 0.005*‡ 
Single biceps curl on the SA (reps) 15 17 2 2.53 0.001* 
Single biceps curl on the NSA (reps) 15 17 2 2.65 0.001* 
Single triceps pushdown on the SA 
(reps) 
23 25 2 5.14 0.116 
Single triceps pushdown of the NSA 
(reps) 
22 25 3 5.43 0.027* 
Sit and reach of the SA (in) -3.4 -3.5 -0.1 5.80 0.985 
Sit and reach of the NSA (in) -4.2 -4.7 -0.5 3.50 0.518 
*Statistically significant (p≤0.05) 
**Statistical trend  
‡ P-value obtained from the Wilcoxon signed-rank test  
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10RM – 10 repetitions maximum  
SA – surgical arm  













Total energy intake      
            Kcal/d 1803.8 1328.6 -475.2 1084.1 0.077‡ 
Carbohydrate intake      
            g/d 191.6 181.3 -10.3 132.3 0.738 
            % of Energy  45.3 55.1 10.0 17.0 0.020* 
Total fat intake      
            g/d 85.9 43.1 -42.8 72.2 0.027*‡ 
            % of Energy 39 29.2 -9.7 18.0 0.030* 
Protein intake      
            g/d 76.7 57.7 -19.0 43.4 0.073** 
           % of Energy 18.0 17.0 -0.6 8.6 0.754 
Fiber intake      
           g/d 23.9 21.0 -4.7 21.8 0.658‡ 
Omega-3 intake      
           g/d 1.9 1.42 -0.9 3.2 0.687‡ 
 
‡ P-value obtained from the Wilcoxon signed-rank test  
 
Anthropometric measurements in breast cancer survivors 
The resting heart rate significantly increased from baseline (B) to 10-weeks (B, 69 ± 9 
bpm vs 10-wk, 73 ± 9 bpm, p=0.032). The systolic blood pressure significantly decreased (B, 128 
± 15 mmHg vs 10-wk, 117 ± 13 mmHg, p=0.001). The diastolic blood pressure demonstrated a 
statistical trend (B, 73 ± 12 mmHg vs 10-wk, 70 ± 10 mmHg, p=0.07).  
  22 
The body mass index significantly decreased (B, 33.6 ± 6.9 kg/m2 vs 10-wk, 32.7 ± 6.1 
kg/m2, p=0.006). The body weight significantly decreased (B, 87.6 ± 4.5 kg vs 10-wk, 85.2 ± 4.0 
kg, p=0.007). Figure 1 demonstrates that 6 of the 19 participants achieved a clinical meaningful 
weight loss of at least 5% after 10 weeks.  
Figure 1: Percentage of weight loss at week 10 
The waist circumference significantly decreased (B, 107.7 ± 11.0 cm vs 10-wk, 103.2 ± 
10.6 cm, p=0.001). The hip circumference significantly decreased (B, 118.9 ± 16.0 cm vs 10-wk, 
115.8 ± 14.4 cm, p=0.025). The volume of the surgical arm significantly decreased (B, 2897.5 ± 
871.8 mL vs 10-wk, 2698.0 ± 724.0 mL, p=0.002). The volume of the non-surgical arm 
significantly decreased (B, 2651.8 ± 721.4 mL vs 10-wk, 2455.6 ± 571.0 mL, p=0.001). Figure 2 
demonstrates the reduction in volume of the arm of the surgical and non-surgical side of each 
participant. Within the women with BCRL, a positive significant correlation exists between the 
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Figure 2: Change in arm volume at week 10 




Body composition in breast cancer survivors  
The total body water significantly decreased (B, 38.2 ± 6.4 L vs 10-wk, 37.2 ± 5.3 L, 
p=0.028). In relation to the body composition, the percentage to which the total body content 
comprised in the body did not significantly changed (B, 43.0% ± 3.7% vs 10-wk, 43.8 ± 4.0%, 
p=0.868). When we examine the fluid compartments, the intracellular fluid significantly 
decreased (B, 21.9 ± 3.8 L vs 10-wk, 21.2 ± 3.2 L, p=0.027).  The absolute extracellular fluid did 
not significantly change but showed a statistical trend (B, 16.2 ± 2.6 L vs 10-wk, 15.9 ± 2.3 L, 



















Figure 2. Change in arm volume at week 10
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Figure 3. Correlation of changes in arm volume and body weight among women with BCRL
r=0.595
p=0.054
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p=0.060). Similarly, the percentage of absolute intracellular fluid significantly changed (B, 21.9 
± 3.81% vs 10-wk, 21.2 ± 3.16%, p=0.025). The percentage to which the extracellular fluid 
comprise the body significantly changed (B, 42. 6 ± 1.39% vs 10-wk, 43.0 ± 1.57%, p=0.055). 
The percentage to which the intracellular fluid comprise the body did not significantly change (B, 
57.4 ± 1.39% vs 10-wk, 57.1 ± 1.6%, p = 0.169). The change in fat mass is demonstrated in 
figure 4, although there is no significant change (B, 36.0 ± 11.9 kg vs 10-wk, 35.1 ± 11.5 kg, 
p=0.126). The fat free mass significantly decreased (B, 52.1 ± 8.7 kg vs 10-wk, 50.7 ± 7.2 kg, p= 
0.027). The percentage to which the fat mass contributes to the body weight did not significantly 
change (B, 40.0 ± 5.1 kg vs 10-wk, 40.1 ± 5.5 kg, p= 0.910). The percentage to which the fat free 
mass contributes to the body weight did not significantly changed (B, 60.0 ± 5.1 kg vs 10-wk, 
59.7 ± 5.5 kg, p=0.660).  
Figure 4: Change in fat mass at week 10 
 
 
Total body muscular strength and endurance  
A gradual increase of stress on the body is achieved by increasing the volume of the 
training sessions on a weekly basis to follow the progressive overload principle (Figure 5). The 
amount of weights lifted per session represents the training volume. Body weight and theraband 
exercises were introduced the first four sessions to prepare for the use of the resistance machine 
exercise that starts at the fifth session. The training volume significantly increased (session 5, 
3138 ± 962 lbs vs session 20, 4219 ± 1915 lbs, p=0.005). From session 5-12, the participants 
increased their upper body and lower body training volume by 23% and 41%, respectively. The 
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handgrip strength increased after 10 weeks of intervention, although the results are not 
significantly different (B, 44 ± 11 kg vs 10-wk, 47 ± 12 kg, p=0.253). The leg-press significantly 
increased (B, 128 ± 43 lbs vs 10-wk, 158 lbs ± 52 lbs, p=0.005). The chest-press significantly 
increased (B, 33 ± 8 lbs vs 10-wk, 38 ± 5 lbs, p=0.001). The number of single arm biceps curl 
repetition (reps) with a five pounds dumbbell on the affected side significantly increased (B, 15 ± 
5 reps vs 10-wk, 17 ± 5 reps, p=0.001). The number of single arm biceps curl repetition with a 
five pounds dumbbell on the non-affected side significantly increased (B, 15 ± 5 reps vs 10-wk, 
17 ± 5 reps, p=0.001). The number of single arm triceps pushdown repetitions on the affected 
side did not change significantly (B, 23 ± 7 reps vs 10-wk, 25 ± 7 reps, p=0.116). The number of 
single arm biceps curl repetitions on the non-affected side significantly increased (B, 22 ± 6 reps 
vs 10-wk, 25 ± 7 reps, p=0.027).  
Figure 5: Mean of training volume progressions over 10 weeks 
 
Flexibility  
The sit and reach results did not significantly change on the surgical and the non-surgical 
side after the 10 weeks of intervention (B, -3.4 ± 3.3 in. vs -3.5 ± 5.8 in, p=0.985 and B, -4.2 ± 
2.9 in vs -4.7 ± 4.9 in, p=0.518).  
Effect size 
The effect size indicates the magnitude of the difference between baseline and week-10. 
The Cohen d. The effect size is large for the systolic blood pressure (d=0.81) and chest press 
(d=0.82). The effect size is medium for the resting heart rate (d=0.47), waist circumference 




















Figure 5. Mean of training volume progressions over 10 weeks
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(d=0.43), leg press (d=0.64), biceps curl of the surgical and non-surgical side (d=0.44 and 
d=0.50), and the triceps pushdown of the non-surgical side (d=0.47). The effect size is small for 
the diastolic blood pressure (d=0.36), BMI (d=0.14), body weight (d=0.13), hip circumference 
(d=0.21), arm volume of the surgical and non-surgical side (d=0.26 and d=0.31), total body water 
(d=0.18), absolute and relative extracellular fluid (d=0.13 and d=0.23), absolute and relative 
intracellular fluid (d=0.20 and d=0.18), absolute fat mass (d=0.08), handgrip (d=0.21), triceps 
pushdown of the surgical side (d=0.29), and chair sit-and-reach of the non-surgical side (d=0.14). 
The effect size is very small for relative total body water (d=0.01), relative fat mass (d=0.04), and 
chair sit-and-reach of the surgical side (d=0.01). 
Discussion  
The study is the first to closely monitor the fitness and diet components of the 
intervention by combining supervised training sessions and providing prepared meals targeted for 
breast cancer survivors.  
Following the 10-week intervention, the compliance to the training sessions and the 
recommended daily calories intake in breast cancer survivors was 88% and 83% respectively. 
The breast cancer survivors started the study with a mean BMI of 33.6 kg/m2 that would be 
classified as obese, and a mean initial daily caloric intake of 1804 kilocalories. The high 
compliance to the intervention demonstrates our intervention may have an impact on the lifestyle 
behavior of the breast cancer survivors. The exercise intervention was designed such that the 
participants engage to a progressive training session of one hour each, making 120 minutes of 
exercise per week. The first two weeks consisted of exercises at light to moderate intensity. The 
following eight weeks consisted of exercises at moderate to vigorous intensity. Despite not 
reaching the minimum requirement of 150 minutes per week of physical activity at moderate 
intensity or equivalent amount of 75 minutes at vigorous intensity, the breast cancer survivors in 
our study significantly decreased BMI, body weight, and waist circumference, all of which being 
risk factors of cardiovascular and metabolic disease and co-morbidities.  Having the training 
sessions supervised by a qualified exercise professional, receiving dietary counselling from a 
registered dietician, and receiving prepared meals on a weekly basis are promising strategies to 
improve the lifestyle behavior of breast cancer survivors who are sedentary and had a BMI 
greater than 24.9 kg/m2. The degree to which the exercise and the nutritional intervention has an 
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impact on the lifestyle behavior of the breast cancer survivors is not confirmed as we did not 
include a control group. A recent weight loss intervention involving meal replacement and home-
based exercise did not demonstrate an improvement of the outcome of lymphedema. Although 
safe, the randomized control trial confirms the need for a facility-based exercise program for 
greater benefits specifically for lymphedema (Schmitz et al., 2019). The American College of 
Sports Medicine (ACSM) also suggests that the preferred setting for exercise for persons with 
cancer is a supervised program under the direction of a fitness professional (American College of 
Sports Medicine et al., 2016) 
With regards to our primary outcome, we hypothesized that a combination of exercise and 
nutrition would decrease body weight by 5-7% after 22 weeks. A weight loss greater than or 
equal to 5% reduces the incidence of breast cancer (Pan et al., 2019). Our preliminary results 
demonstrate the effect of 10 weeks of supervised bi-weekly training sessions, nutrition 
counselling, and intake of prepared meals targeted for breast cancer survivors.  The 10-week 
intervention demonstrated a significant decrease in body weight (p=0.007) in breast cancer 
survivors, with a mean change of -2.7%. Comparatively, the WISER study combined a 20-week 
meal replacements and 52 weeks of home-based exercise program including bi-weekly resistance 
training and 180 minutes of walking per week, and reported a mean change of body weight of -
8.06% in the combined group (Schmitz et al., 2019). Although our study followed a similar 
intervention plan, our results are only reflected by a 10-week intervention of prepared meals and 
bi-weekly training sessions. Although a decrease of 5-7% of body weight over the 22-week of 
intervention was hypothesized, 6 of the 19 participants from our study achieved the clinical 
meaningful weight loss of at least 5% of baseline body weight after only 10 weeks (Figure 1). 
Comparatively, the Stepping STONE study assessed 22 black breast cancer survivors, in which 
10 participants received nutrition education, exercise session, and survivor-led motivational 
interviewing phone sessions for 12 weeks (Sheppard et al., 2016). The Stepping STONE study 
reported an overall adherence of 70% and despite the aim of 5% weight loss, the mean weight 
loss was 0.8% (Sheppard et al., 2016).  
While a weight reduction of 5% is considered clinically meaningful, a weight loss at a 
rate of 0.5-1 kilograms per week is recommended, which signifies a loss of 5-10 kilograms of 
body weight is expected at week 10 of our study. Our study demonstrates that 64% of our 
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participants reached the target weight loss. Of the breast cancer survivors who achieved the 
suggested weight loss of 5-10 kilograms at week 10, 71% have BCRL.  
Management of body weight may be affected by several factors that are out of our 
control, including treatment and medications. Although tamoxifen is widely thought to be 
responsible for weight gain in breast cancer survivors, there is no evidence supporting this 
statement. A study by Demark-Wahnefried reports that patients undergoing chemotherapy tends 
to gain more body weight compared to patients receiving localized therapy alone (Demark-
Wahnefried et al., 2012). In our study sample, 79% of our participants had chemotherapy. Other 
factors affecting management of body weight include level of stress, quality of sleep, the cultural 
background of the participants, and environmental factors. 
The risk of development of breast cancer differs among premenopausal women and 
postmenopausal women. Although weight gain is not recommended, women with BMI greater 
than 24.9 kg/m2 are reported to have a 20-40% lower risk of breast cancer (Schoemaker et al., 
2018). The mechanism of the protective effect from a high BMI in premenopausal women is still 
unknown (Schoemaker et al., 2018).  On the other hand, an increase of 5 kg/m2 after menopause 
is associated with a 2% increase risk of breast cancer (Liu et al., 2018).  Our study involves 
postmenopausal women and a significant decrease in BMI was observed. The management of 
BMI is a modifiable factor that reduces the risk of breast cancer recurrence in postmenopausal 
women, as there is a link between higher BMI and onset of hormone receptor-positive breast 
cancer (Dignam, 2003). A greater reduction in BMI is associated with positive health outcomes 
by reducing the risk of developing cardiovascular and metabolic diseases. Although the BMI is a 
measure of the body fat, the proportion of fat mass contributing to the body weight differs among 
women with the same BMI. The amount of fat tissue may be the link between the high BMI and 
risk of breast cancer.  
A significant reduction in waist circumference was also demonstrated. The circumference 
of the waist is an indicator of visceral fat and is associated with cardiovascular and metabolic 
diseases and co-morbidities. The visceral fat is a clinical marker of insulin resistance and 
metabolic syndrome (Ravasco, 2010). An excess amount of insulin circulating in the blood 
reduces level of sex hormone binding globulin (SHBG). SHBG is a glycoprotein that binds to 
androgens and estrogens, and therefore plays a role in controlling estradiol. A reduction in SHBG 
increases circulating estradiol and thereby increases the risk of developing breast cancer (Key et 
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al., 2001). The increase of the adipose tissue in the body occurs through hyperplasia and 
hypertrophy of the adipocyte, which are induced through an excess amount of caloric intake or 
lower caloric expenditure. The excess amount of adipose tissue in breast cancer survivors may 
increase the risk of cancer recurrence, as the adipose tissue produces hormones including 
estrogen, leptin, and pro-inflammatory cytokines, all of which may be contributing to the 
development of cancer. The binding of the estrogen with the estrogen receptor in the breast cell 
induces the growth of the breast cell. The leptin increases the development and progression of the 
growth of the tumor by binding on the transmembrane leptin receptor, which increases the cell 
proliferation through a signaling pathway (Andò et al., 2019). The pro-inflammatory cytokines 
are proteins that regulate the microenvironment of the inflammatory tumor, stimulating the 
proliferation and invasion of the cancer cell (Nicolini et al., 2006). Thus, inflammation induced 
by the excess of adipose tissue may be the physiological connection between obesity and the 
development of breast cancer. A non-randomized control trial compared the effect of low 
carbohydrate and low fat diet by providing a structured diet plan intervention over a 6-month 
period and reported a significant decrease in body weight (12.5%), body fat (27.5%), waist 
circumference (9.5%), and hip circumference (7.8%), and decrease in fat free mass (1.3%) 
(Thompson et al., 2015).  
An increase in fat free mass and a decrease in fat mass is recommended to minimize the 
adverse effects from a body composition high in fat mass. Increase in fat free mass and decrease 
in fat mass can be achieved through regular resistance training, at minimum two times per week. 
Resistance training is widely known to increase fat free mass and improving and maintaining 
muscular strength.  While resistance training improves the composition of the body, the intake of 
aromatase inhibitor such as anastrozole may affect the body density and its capacity to maintain 
lean mass. Despite the contradicatory effect on body composition between resistance training and 
aromatase inhibitors, the Hormones and Physical Exercise (HOPE) study demonstrated an 
increase in fat free mass and decrease in percentage of fat mass in breast cancer survivors taking 
aromatase inhibitors (Thomas et al., 2017). Qualified exercise professionals supervised the 
training sessions during the first 10 week of our study with the intention to incorporate 
progressive overload while ensuring the safety of the exercise performed. Progression overload 
intends to add gradual stress on the body to ensure improvement in fitness (Figure 2).  
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Despite the progressive training volume and a significant increase in training volume 
(p=0.001), our results demonstrate a significant decrease in absolute fat free mass (p=0.027) 
along with a non-significant decrease in absolute fat mass (p=0.124). Although the change in 
muscle mass is not measured, the signicant decrease in fat free mass may be attributable to the 
significant decrease in total body water. The results suggests that the body weight loss observed 
in our study is reflected by the significant decrease in total body water and statistically trending 
decrease in absolute fat free mass. The 6-month telephone-delivered behavioral weight loss 
intervention from the Living Well after Breast Cancer pilot trial demonstrated similar results, in 
which a decrease in fat mass and fat free mass measured from the bioimpedance spectroscopy 
resulted with a reduction in body weight (Reeves et al., 2017). Fat free mass is expected to 
decrease with a reduction in body weight (Heymsfield et al., 2014). The mean age of our 
participants is 62 years old and 45% takes tamoxifen and aromatase inhibitors, both of which are 
risk factors for loss of bone density.  Despite the decrease in absolute fat free mass observed from 
our study, the relative fat free mass was maintained. Although an increase in relative fat free 
mass is recommended, the maintenance of relative fat free mass along with a decrease in body 
weight is a favorable outcome as long as the relative fat free mass does not decrease.   
 With regards to the water content of the body, hydration is important to maintain the 
control of cellular protein turnover that may affect oncotic pressure.  The normal range of total 
body water is 55-60% in men and 50-55% in women to maintain overall health (Stefani, Laura et 
al., 2017). The ratio of intracellular fluid and extracellular fluid of 3:2 is recommended in cancer 
patients to maintain overall physiologic and cognitive functions (Stefani et al., 2017). Our results 
demonstrate that the significant reduction in body weight resulted in a significant reduction in 
absolute total body water content. The relative total body content did not significantly change, 
although the values are below the recommended level. Our results also demonstrate that the ratio 
of intracellular fluid and extracellular fluid is 2.7:2. The ratio of our study suggests that that there 
is a greater amount of extracellular fluid. Although 58% of the participants have BCRL, the ratio 
of 2.7:2 remains the same when comparing the ratio between BCRL and BC without 
lymphedema subgroup. The exercise and dietary intervention seem to not affect the level of 
extracellular fluid in the body.  
Our study observed the dietary changes influenced by the nutritional counselling, the 
provided prepared meals, and the cooking classes. The present preliminary results reflect the 
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changes induced by the nutritional counselling and provided prepared meals only, because the 
cooking classes were given after week 10. Despite an average reduction in daily caloric intake of 
475 kilocalories from baseline to week 10, the changes showed a statistical trend (p=0.072). The 
statistical trending decrease in daily caloric intake suggest that the prepared meals and the 
nutritional counselling may have a beneficial effect on weight loss, as 74% of the breast cancer 
survivors achieved a clinical meaningful weight loss after 10 weeks. Interestingly, the caloric 
intake of the participants with BCRL significantly decreased from baseline to week 10, 
suggesting that there may be a learning effect from the nutritional counselling and the provided 
prepared meals on the dietary habit of the participants with BCRL.  
A dose response relationship between dietary fat and weight loss indicates that dietary fat 
plays a role in management of body weight. A reduction of 10% of dietary fat induce a weight 
loss of 4-5kg in individuals with an initial BMI of 30 kg/m2 (Institute of Medicine, 2003). The 
mean initial BMI of our population is 33.6 kg/m2. Weight loss achieved through a diet composed 
of 20-30% of energy from fat is more achievable than a severely restricted low-fat diet with 
energy from fat contributing to 20% of the total energy intake (Kris-Etherton et al., 2002). The 
results from our study show a significant drop of energy from dietary fat from 39% at baseline to 
29.2% at week 10 (p=0.027), along with a significant weight reduction of 2.4kg (p=0.007).  
Similar results are observed from the randomized control trial that included a low-fat diet of 20% 
of total energy intake through dietary counselling (Shaw et al., 2007a). The randomized control 
trial reported a significant weight reduction of 2.9kg after 24 weeks of intervention (p=0.006), 
along with a significant reduction in energy intake from dietary fat of 26% (p=0.001) (Shaw et 
al., 2007a). The link between dietary fat and risk of breast cancer is inconclusive, with several 
studies demonstrating contradicting results, ranging from positive relation to no association 
(Ravasco, 2010). Studies report that dietary fat, specifically saturated fat, increases the 
production of estrogen, a main determinant for risk of breast cancer (Ravasco, 2010).   
The combination of our dietary and exercise intervention shows a significant reduction of 
systolic blood pressure by week 10.  Similar results are observed from the ENERGY trial study, 
which aimed to reduce body weight of breast cancer survivors with a BMI between 25 and 48 
kg/m2 through group-based cognitive-behavioral weight loss program. The program was 
designed to reduce energy intake relative to expenditure and increase physical activity. In 
addition to demonstrating a significant weight loss, the ENERGY trial study demonstrated a 
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significant decrease in systolic blood pressure at 6, 12, 18, and 24 months (Rock et al., 2015). 
The combination of a dietary and exercise intervention seems to benefit the reduction of blood 
pressure; although, it would be interesting to determine whether the exercise or the nutrition has a 
more prominent effect on the systolic blood pressure. Although our main focus was not to reduce 
the blood pressure, our protocol of prepared meals follows the similar idea of the Dietary 
Approaches to Stop Hypertension (DASH) diet. The DASH diet aims to reduce blood pressure by 
recommending a diet that is rich in fruits, vegetables, and low-fat dairy products, and lower 
saturated fat and cholesterol. Our prepared meals and nutrition counselling were specifically 
targeted to prevent recurrence of breast cancer by reducing body weight. We encourage higher 
intake in fruits and vegetables, omega-3, fibers, and protein. Comparatively, the Women’s 
Healthy Eating and Living (WHEL) study demonstrated that following a dietary group 
intervention, participants with history of breast cancer within the previous four years significantly 
increased intake of fruits by 25%, vegetables by 65%, and fibers by 30% and decreased intake of 
fat by 13%, but no significant weight loss was observed, with one kilogram difference in average 
weight at any time point of the study (Pierce et al., 2007).  
A higher intake of omega-3 is recommended for breast cancer survivors as studies 
demonstrate a protective effect to prevent the recurrence of breast cancer (Fabian et al., 2015).  
The omega-3 has properties capable of generating bioactive lipid mediators that modulate 
inflammation, hence delaying the development of breast cancer (Spencer et al., 2009). Although 
the recommended daily intake of omega-3 for women is 1.1g, the recommendation of daily intake 
of omega-3 is higher in breast cancer survivors. Prior to starting the study, the participants 
consumed 172.6% of the recommended daily allowance of omega-3. Despite increasing the 
awareness of increasing omega-3 in the daily meals, the breast cancer survivors from our study 
reduced their daily intake by 0.94g of omega-3. The reduction in omega-3 intake may be 
reflected by the reduction in daily food intake of the participants.  Despite a reduction in daily 
intake of omega-3, the participants consumed omega-3 130% more than the recommended intake 
at week 10.  
 All of our participants are breast cancer survivors with 58% having BCRL, and none 
demonstrated worsening outcomes regarding lymphedema during the 10-week study. The results 
obtained from the BCRL subgroup demonstrated that 55% of the women with BCRL achieved 
the clinical meaningful weight loss of 5%. Patients with BCRL are recommended to maintain a 
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normal BMI because obesity may be associated with inflammation and worsening of 
lymphedema (Borman, 2018). Several factors may contribute to the increase of volume of the 
arm. The complications occurring after the treatment may affect the efficiency of the extrinsic 
force from the skeletal muscle contractions and the intrinsic force from the active pumping of the 
collecting vessel network, all of which help move the lymph against a hydrostatic pressure 
gradient (Scallan et al., 2016). Excess amount of body fat may also increase the volume of the 
arm. The excess of subcutaneous fat may disrupt the deep lymphatic channels, which affect the 
functions of the lymphatic system and thus, creating more inflammation. Our second hypothesis 
was that the women with BCRL would significantly decrease the arm volume of the affected side 
with the combined exercise and dietary intervention. In our study, the volume of the affected arm 
and the unaffected arm reduced significantly, with a mean difference of -200.0 mL (-6.4%, 
p=0.031) and -185.5 mL (-6.8%, p=0.017), respectively. The interlimb volume difference did not 
show a significant difference, which agrees with several studies reporting that exercise do not 
worsen the lymphedema symptoms. A study demonstrated that despite no change in volume of 
the arm, there was an improvement in composition of the arm with exercise alone (Zhang et al., 
2017). The dual-energy x-ray absorptiometry revealed that after 12-months of resistance training, 
a greater lean mass and body mass density, and a decrease in fat percentage of the affected arm 
were observed (Zhang et al., 2017).  
A pilot study recruited 21 participants with BCRL who were randomized into a weight-
reduction group (n=11) who which received dietary advice to reduce calorie intake by 1000-1200 
kilocalories and control group (n=10) who did not receive a dietary intervention. The pilot study 
demonstrated a significant correlation exists (r=0.513, p=0.017) between weight loss and 
reduction in volume of the affected arm through a 12-week intervention of individualized dietary 
advice (Shaw et al., 2007b). The pilot study reported a significant difference in body weight and 
BMI, with a mean decrease of -3.3kg and -1.3 kg/m2, respectively after the 12-week of dietary 
intervention. Similarly, our results indicate a significant loss in body weight of -2.3kg and a 
significant decrease in BMI of -0.9 kg/m2 in women with BCRL. The Pearson correlation test 
showed a positive statistically significant correlation between percent arm volume reduction and 
body weight (r=0.595, p=0.054). The main difference between our study and Shaw’s pilot study 
is that we recommended a calorie deficit of 500 kilocalories instead of 1000-1200 kilocalories, 
and we added the fitness component with the idea that a greater effect on body weight and BMI 
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could occur. Although a reduction in arm volume was observed in our study, it lacks information 
about the tissue composition of the arm. Different mechanisms may explain the reduction in 
volume of the arm, including a reduction in excess amount of fluid, or that the anti-inflammatory 
properties of the diet may have reduced the inflammation caused by the lymphedema. Although 
the bioelectrical impedance analysis used to assess the body composition do not focus on the 
composition of the tissue of the arm, our results demonstrate a significant decrease in total body 
water in women with BCRL (p=0.048), but the total body extracellular fluid was not significantly 
different (p=0.31), suggesting that the accumulation of fluid commonly that resulted to 
lymphedema is not affected by the intervention. Another possible mechanism that may result in a 
decrease in arm volume is the loss of localized subcutaneous fat mass in the affected and 
unaffected arm. The absolute fat mass in women with BCRL, although not specifically reflected 
by the composition of the affected arm, was not significantly different (p=0.448). A future study 
examining the effect of supervised training session and dietary intervention on the composition of 
the tissue of the arm would provide additional insight on what caused the volume of the arm to 
decrease.  
Conclusion 
As weight gain is a common risk factor in breast cancer survivors and as survival rates 
keep on increasing, management of the modifiable factors are important to maintain good quality 
of life. Chronic fatigue, fear of cancer recurrence, body image issue, and depression, are 
examples of barriers affecting the feasibility of breast cancer survivors to engage in a healthier 
lifestyle. As such, breast cancer survivors are prone to a sedentary lifestyle and poor eating habit. 
Our findings support the efficacy of supervised training sessions combined with prepared meals 
for breast cancer survivors. Our results demonstrate that breast cancer survivors who had a 
sedentary lifestyle and a BMI greater than 24.9 kg/m2 were able to adhere to progressive training 
program of two sessions of 60 minutes per week and to receive prepared meals. We hypothesized 
that our study would generate a clinical meaningful five to seven percent decrease in body weight 
after the 22-week intervention. Our preliminary results demonstrate the effect over the 10 weeks. 
After 10-weeks of the intervention, our participants significantly loss body weight, with the mean 
change of -2.7%, along with a significant decrease in volume of the arm. The data of the 22-week 
intervention would provide more information about how the supervised training sessions and 
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prepared meals may impact the behavioral changes in breast cancer survivors without in-person 
interactions, and its impact on the weight and body composition.  
A randomized control trial with larger sample size would provide more insight on the 
effect of the exercise and the prepared meals individually on the body weight and volume of the 
arm of breast cancer survivors. Additionally, as women with BCRL significantly decreased the 






























Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017). Awareness and current knowledge of 
breast cancer. Biological Research, 50(1), 33. https://doi.org/10.1186/s40659-017-0140-9 
Alsaker, M. D. K., Janszky, I., Opdahl, S., Vatten, L. J., & Romundstad, P. R. (2013). Weight 
change in adulthood and risk of postmenopausal breast cancer: The HUNT study of 
Norway. British Journal of Cancer, 109(5), 1310–1317. 
https://doi.org/10.1038/bjc.2013.403 
American College of Sports Medicine, Moore, G., Durstine, L., & Painter, P. (2016). ACSM’s 
Exercise Management for Persons with Chronic Diseases and Disabilities-4th Edition (4th 
ed.). Human Kinetics. 
Andò, S., Gelsomino, L., Panza, S., Giordano, C., Bonofiglio, D., Barone, I., & Catalano, S. 
(2019). Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed 
Mechanisms. Cancers, 11(1), 62. https://doi.org/10.3390/cancers11010062 
Borman, P. (n.d.). Lymphedema diagnosis, treatment, and follow-up from the view point of 
physical medicine and rehabilitation specialists. 19. 
Bower, J. E. (2014). Cancer-related fatigue—Mechanisms, risk factors, and treatments. Nature 
Reviews Clinical Oncology, 11(10), 597–609. https://doi.org/10.1038/nrclinonc.2014.127 
Demark-Wahnefried, W., Campbell, K. L., & Hayes, S. C. (2012). Weight management and its 
role in breast cancer rehabilitation. Cancer, 118(S8), 2277–2287. 
https://doi.org/10.1002/cncr.27466 
Dignam, J. J. (2003). Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen 
Receptor-Positive Early-Stage Breast Cancer. CancerSpectrum Knowledge Environment, 
95(19), 1467–1476. https://doi.org/10.1093/jnci/djg060 
Fabian, C. J., Kimler, B. F., & Hursting, S. D. (2015). Omega-3 fatty acids for breast cancer 
prevention and survivorship. Breast Cancer Research, 17(1), 62. 
https://doi.org/10.1186/s13058-015-0571-6 
Freedman, R. J., Aziz, N., Albanes, D., Hartman, T., Danforth, D., Hill, S., Sebring, N., 
Reynolds, J. C., & Yanovski, J. A. (2004). Weight and Body Composition Changes 
during and after Adjuvant Chemotherapy in Women with Breast Cancer. The Journal of 
Clinical Endocrinology & Metabolism, 89(5), 2248–2253. 
https://doi.org/10.1210/jc.2003-031874 
Gross, A. L., May, B. J., Axilbund, J. E., Armstrong, D. K., Roden, R. B. S., & Visvanathan, K. 
(2015). Weight Change in Breast Cancer Survivors Compared to Cancer-Free Women: A 
Prospective Study in Women at Familial Risk of Breast Cancer. Cancer Epidemiology 
Biomarkers & Prevention, 24(8), 1262–1269. https://doi.org/10.1158/1055-9965.EPI-15-
0212 
Helyer, L. K., Varnic, M., Le, L. W., Leong, W., & McCready, D. (2010). Obesity is a Risk 
Factor for Developing Postoperative Lymphedema in Breast Cancer Patients. The Breast 
Journal, 16(1), 48–54. https://doi.org/10.1111/j.1524-4741.2009.00855.x 
Heymsfield, SB, Gonzalez, MC, Redman, Shen W., & Thomas, D. (2014). Weight loss 
composition is one-fourth fat-free mass: A critical review and critique of this widely cited 
rule. Obesity Review, 15, 310–321. 
  37 
Institute of Medicine. (2003). Weight-Loss and Maintenance Strategies. In Weight Mangement: 
State of the Science and Opportunities for Military Programs. The National Academies 
Press. 
Irwin, M. L., McTiernan, A., Bernstein, L., Baumgartner, R., & Baumgartner, K. (2010). 
Physical activity levels among breast cancer survivors. 17. 
Key, T. J., Allen, N. E., Verkasalo, P. K., & Banks, E. (2001). Energy balance and cancer: The 
role of sex hormones. Proceedings of the Nutrition Society, 60(1), 81–89. 
https://doi.org/10.1079/PNS200068 
Kris-Etherton, P., Binkoski, A., Zhao, G., Coval, S., Clemmer, K., Hecker, K., Jacques, H., & 
Etherton, T. (2002). Dietary fat: Assessing the evidence in support of a moderate-fat diet; 
the benchmark based on lipoprotein metabolism. Proceedings of the Nutrition Society, 
61(2), 287–298. https://doi.org/10.1079/PNS2002157 
Liu, K., Zhang, W., Dai, Z., Wang, M., Tian, T., Liu, X., Kang, H., Guan,  haitao, Zhang, S., & 
Dai, Z. (2018). Association between body mass index and breast cancer risk: Evidence 
based on a dose&ndash;response meta-analysis. Cancer Management and Research, 
Volume 10, 143–151. https://doi.org/10.2147/CMAR.S144619 
Meeske, K., Smith, A. W., Alfano, C. M., McGregor, B. A., McTiernan, A., Baumgartner, K. B., 
Malone, K. E., Reeve, B. B., Ballard-Barbash, R., & Bernstein, L. (2007). Fatigue in 
breast cancer survivors two to five years post diagnosis: A HEAL Study report. Quality of 
Life Research, 16(6), 947–960. https://doi.org/10.1007/s11136-007-9215-3 
Mehrara, B. J., & Greene, A. K. (2014). Lymphedema and Obesity: Is There a Link? Plastic and 
Reconstructive Surgery, 134(1), 154e–160e. 
https://doi.org/10.1097/PRS.0000000000000268 
Nicolini, A., Carpi, A., & Rossi, G. (2006). Cytokines in breast cancer. Cytokine & Growth 
Factor Reviews, 17(5), 325–337. https://doi.org/10.1016/j.cytogfr.2006.07.002 
Norman, S. A., Localio, A. R., Potashnik, S. L., Simoes Torpey, H. A., Kallan, M. J., Weber, A. 
L., Miller, L. T., DeMichele, A., & Solin, L. J. (2009). Lymphedema in Breast Cancer 
Survivors: Incidence, Degree, Time Course, Treatment, and Symptoms. Journal of 
Clinical Oncology, 27(3), 390–397. https://doi.org/10.1200/JCO.2008.17.9291 
Ozaslan, C., & Kuru, B. (2004). Lymphedema after treatment of breast cancer. The American 
Journal of Surgery, 187(1), 69–72. https://doi.org/10.1016/j.amjsurg.2002.12.003 
Pan, K., Luo, J., Aragaki, A. K., & Chlebowski, R. T. (2019). Weight loss, diet composition and 
breast cancer incidence and outcome in postmenopausal women. Oncotarget, 10(33). 
https://doi.org/10.18632/oncotarget.26864 
Pierce, J. P., Natarajan, L., Caan, B. J., Parker, B. A., Greenberg, R., Flatt, Shirley W., Rock, 
Cheryl, Kealey, Sheila, Al-Delaimy, Wael K., Bardwell, Wayne A., Carlson, Robert W., 
Emond, Jennifer A., Faerber, Susan, Gold, Ellen B., Hajek, Richard A., Hollenbach, 
Kathryn, Jones, Lovell A., Karanja, Njeri, Madklensky, Lisa, … Stefanick, Marcia. 
(2007). Influence of a Diet Very High in Vegetables, Fruit, and Fiber and Low in Fat on 
Prognosis Following Treatment for Breast Cancer: The Women’s Healthy Eating and 
Living (WHEL) Randomized Trial. Journal of the American Medical Association, 298(3), 
289–298. 
Ravasco, P. (2010). Body fat and poor diet in breast cancer women. NUTRICION 
HOSPITALARIA, 3. https://doi.org/10.3305/nh.2010.25.3.4418 
REEVES, M., WINKLER, E., MCCARTHY, N., LAWLER, S., TERRANOVA, C., HAYES, S., 
JANDA, M., DEMARK-WAHNEFRIED, W., & EAKIN, E. (2017). The Living Well 
  38 
after Breast Cancer Pilot Trial: A weight loss intervention for women following treatment 
of breast cancer. Asia-Pacific Journal of Clinical Oncology, 13, 125–136. 
Rock, C. L., Flatt, S. W., Byers, T. E., Colditz, G. A., Demark-Wahnefried, W., Ganz, P. A., 
Wolin, K. Y., Elias, A., Krontiras, H., Liu, J., Naughton, M., Pakiz, B., Parker, B. A., 
Sedjo, R. L., & Wyatt, H. (2015). Results of the Exercise and Nutrition to Enhance 
Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss 
Intervention in Overweight or Obese Breast Cancer Survivors. Journal of Clinical 
Oncology, 33(28), 3169–3176. https://doi.org/10.1200/JCO.2015.61.1095 
Scallan, J. P., Zawieja, S. D., Castorena-Gonzalez, J. A., & Davis, M. J. (2016). Lymphatic 
pumping: Mechanics, mechanisms and malfunction: Lymphatic pumping mechanisms. 
The Journal of Physiology, 594(20), 5749–5768. https://doi.org/10.1113/JP272088 
Schmitz, K. H., Troxel, A. B., Dean, L. T., DeMichele, A., Brown, J. C., Sturgeon, K., Zhang, Z., 
Evangelisti, M., Spinelli, B., Kallan, M. J., Denlinger, C., Cheville, A., Winkels, R. M., 
Chodosh, L., & Sarwer, D. B. (2019). Effect of Home-Based Exercise and Weight Loss 
Programs on Breast Cancer–Related Lymphedema Outcomes Among Overweight Breast 
Cancer Survivors: The WISER Survivor Randomized Clinical Trial. JAMA Oncology, 
5(11), 1605. https://doi.org/10.1001/jamaoncol.2019.2109 
Schoemaker, M. J., Nichols, H. B., Brook, M. N., Jones, M. E., O’Brien, K. M., Adami, H.-O., 
Baglietto, L., Bernstein, L., Bertrand, K. A., Boutron-Ruault, M.-C., Braaten, T., Chen, 
Y., Connor, A. E., Dorronsoro, M., Dossus, L., Eliassen, A. H., Giles, G. G., Hankinson, 
S. E., Kaaks, R., … Swerdlow, A. J. (2018). Association of Body Mass Index and Age 
With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncology, 4(11), 
e181771. https://doi.org/10.1001/jamaoncol.2018.1771 
Shaw, C., Mortimer, P., & Judd, P. A. (2007a). Randomized controlled trial comparing a low-fat 
diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer, 109(10), 
1949–1956. https://doi.org/10.1002/cncr.22638 
Shaw, C., Mortimer, P., & Judd, P. A. (2007b). Randomized controlled trial comparing a low-fat 
diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer, 109(10), 
1949–1956. https://doi.org/10.1002/cncr.22638 
Sheppard, V. B., Hicks, J., Makambi, K., Hurtado-de-Mendoza, A., Demark-Wahnefried, W., & 
Adams-Campbell, L. (2016). The feasibility and acceptability of a diet and exercise trial 
in overweight and obese black breast cancer survivors: The Stepping STONE study. 
Contemporary Clinical Trials, 46, 106–113. https://doi.org/10.1016/j.cct.2015.12.005 
Spencer, L., Mann, C., Metcalfe, M., Webb, M., Pollard, C., Spencer, D., Berry, D., Steward, W., 
& Dennison, A. (2009). The effect of omega-3 FAs on tumour angiogenesis and their 
therapeutic potential. European Journal of Cancer, 45(12), 2077–2086. 
https://doi.org/10.1016/j.ejca.2009.04.026 
Stefani, Laura, Palmerini, Davide, Corezzi, Michele, Mascherini, Gabriele, Petri, Cristian, Klika, 
Riggs J., & Galanti, Giorgio. (2017). Total Body Water Distribution in Breast Cancer 
Survivors Following Cancer Rehabilitation. Journal of Functional Morphology and 
Kinesiology, 1–8. https://doi.org/10.3390/jfmk2020012 
Sullivan, G. M., & Feinn, R. (2012). Using Effect Size—Or Why the P Value Is Not Enough. 
Journal of Graduate Medical Education, 4(3), 279–282. https://doi.org/10.4300/JGME-D-
12-00156.1 
Thomas, G. A., Cartmel, B., Harrigan, M., Fiellin, M., Capozza, S., Zhou, Y., Ercolano, E., 
Gross, C. P., Hershman, D., Ligibel, J., Schmitz, K., Li, F.-Y., Sanft, T., & Irwin, M. L. 
(2017). The effect of exercise on body composition and bone mineral density in breast 
  39 
cancer survivors taking aromatase inhibitors: 12-Month Body Composition Changes in 
HOPE. Obesity, 25(2), 346–351. https://doi.org/10.1002/oby.21729 
Thompson, H. J., Sedlacek, S. M., Playdon, M. C., Wolfe, P., McGinley, J. N., Paul, D., & 
Lakoski, S. G. (2015). Weight Loss Interventions for Breast Cancer Survivors: Impact of 
Dietary Pattern. PLOS ONE, 10(5), e0127366. 
https://doi.org/10.1371/journal.pone.0127366 
Wanchai, A., & Armer, J. M. (2019). Effects of weight-lifting or resistance exercise on breast 
cancer-related lymphedema: A systematic review. International Journal of Nursing 
Sciences, 6(1), 92–98. https://doi.org/10.1016/j.ijnss.2018.12.006 
Zhang, X., Brown, J. C., Paskett, E. D., Zemel, B. S., Cheville, A. L., & Schmitz, K. H. (2017). 
Changes in arm tissue composition with slowly progressive weight-lifting among women 





























Limitations and conclusions 
Our study presents with several limitations and challenges. Although our study is a pilot 
study, the size of our sample is small, which generates small statistic power. Due to recruitment 
challenges and feasibility uncertainty, our sample was not randomized, and all participants 
received the same intervention.  
The lack of control group prevents us from explaining what may have caused the 
observed results. The results observed from this single-group pilot study is reflected by the 
combination of both exercise and dietary interventions.  No information is provided from our 
study with regards to which of the two interventions has the most prominent effect on the weight 
and body composition of the breast cancer survivors. A randomized control trial compared the 
effect of lifestyle change interventions in overweight-to-obese post-menopausal women. The 
study compared the effects of aerobic exercise (e.g., five days per week at moderate-to-vigorous 
intensity), and dietary manipulation and counseling on the body weight and body composition. 
The results obtained after 12 months of intervention demonstrated that the three lifestyle change 
interventions led to a significant weight loss, with a greater effect from the combined exercise 
and dietary interventions (Foster-Schubert et al., 2011).   
Although our study was not focusing on the BCRL, body fat percentage assessment on 
the arm would give us more insight on how the intervention affects the composition of the arm, in 
addition to observing a significant difference in volume of the arm. We did not control for the 
time of breast cancer diagnosis, and recruited all women with a history of breast cancer.  
Concluding remarks   
To conclude, our study supports the efficacy of supervised training sessions and prepared meals 
for breast cancer survivors. Our results also support the safety of an exercise intervention at 
vigorous intensity in breast cancer survivors. Despite starting the study with a history of 
sedentary lifestyle and a BMI greater or equal to 25 kg/m2, our study demonstrate that two 
  41 
training sessions of 60 minutes  each week is a feasible starting point to increase the level of 
physical activity in breast cancer survivors and to decrease body weight and volume of the arms. 
Providing the prepared meals contributed to improved eating habit as our participants decreased 
dietary fat intake. Combining supervised training sessions and prepared meals demonstrate 
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Appendix A : 22-weeks progressive training program  
Exercise Protocol 











Sit to stand 
2x10 10RM 
Chest press with 
tubing band 
Low row with 
tubing band 
Biceps curl with 
tubing band 
Triceps extension 
with tubing band 




Modified dead bug  





seated cat cow, 
1x15seconds 
each muscles 













Sit to stand 
2x10 10RM 
Chest press with 
tubing band 
Low row with 
tubing band 
Biceps curl with 
tubing band 
Triceps extension 
with tubing band 




Modified dead bug  
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Biceps curl with 
dumbbells 
  51 
Triceps extension 
with dumbbells 




Modified dead bug  






























3 ways touch on 
balance pad 
2x10 (each leg) 





  52 
walking hands 























3 ways touch on 
balance pad 
2x10 (each leg) 
 
















Appendix B:  Details of the menu  
#1 Breakfast Recipes / Items 
Key nutrition facts   Allergens 
per portion (recipes) per meal CONTAINS: 
MAY 
CONTAIN: 
Banana muffin (1 muffin) Kcal   152 301 
 
 
1 cup yogurt Carb (g)   22 33 Wheat, eggs 
Traces of 
soy, nuts 
  Fibre (g)     3 3   
  Protein (g) 3 12   
  Fat (g) 6 14   
  omega-3 (g) 0.34 0.41     
Cinnamon Oatmeal with 1 
Tablespoon ground 
flaxseed (1/2 cup ~125 ml) 
Kcal   




Carb (g)   17 19   
  Fibre (g)     3 5   
  
Protein (g) 
3 5   
  Fat (g) 2 5   
  omega-3 (g) 1.64 1.64     
Kasha granola bar 
Kcal   





Carb (g)   
27 34   
  Fibre (g)     4 5   
  
Protein (g) 
5 6   
  Fat (g) 4 4   
  omega-3 (g) 0.49 0.49     
Pumpkin muffin 







  54 
(1 muffin) 
Carb (g)   
21 36   
1 fruit of your choice Fibre (g)     2 5   
  
Protein (g) 
3 4   
  Fat (g) 7 8   
  omega-3 (g) 1.15 1.15     
Apple Cinammon 
breakfast risotto 
Kcal   




(take 1 cup - 2 portions) 
Carb (g)   
28 67.5   
1 cup yogurt Fibre (g)     2 3   
  
Protein (g) 
2 12   
  Fat (g) 1 10   



















Quinoa Salad  
250 mL milk 
or kefir, 
orange slices 
 Kcal   203 576 
none Wheat, sulfites 
(take 2 portions 
of  ¾ cup = 1 ½ 
cups) 
Grain Carb (g)   38 103.5 
    F/V Fibre (g)     5 13 
  
Water (1-2 






     Fat (g) 3 9 















and wheat  
(take 1 portion = 
1 cup) 
  Grain Carb (g)   34 53 
    F/V Fibre (g)     3 3 
  
Water (1-2 






     Fat (g) 8 8 
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mustard, soya  
(take 2 muffins = 
2 portions) 
50 g cheddar 
cheese 
Grain Carb (g)   18 59 
    F/V  Fibre (g)     2 9 
  
Water (1-2 






     Fat (g) 6 29 






and rice  






(take 1 cup mole 
+   2/3 cup rice = 
1 portion) 
250 mL milk 
or yogurt 
Grain Carb (g)   47 60 
    F/V Fibre (g)     10 11 
  
Water (1-2 






     Fat (g) 6 10 













(take 2 portions 





Grain Carb (g)   15 54 
    F/V Fibre (g)     3 8 
  
Water (1-2 






     Fat (g) 0.5 19 
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#2 Breakfast Recipes / Items 
Key nutrition facts   Allergens 






Cornbread muffin Kcal   100 358 Wheat, eggs Traces of 
1 muffin Carb (g)   20 35 dairy 
soy and 
nuts 
50 g cheese Fibre (g)     2 2   
125 ml grapes (seedless) Protein (g) 3 16   




0.02 0.21     
Cranberry-orange rice pudding 
Kcal   
120 312 Dairy 
Traces of 
wheat soy 
(Take 1 cup=2 portions) 
Carb (g)   
25 69  and nuts 
1 Apple Fibre (g)     0 3   
  Protein (g) 4 8   
  Fat (g) 0.5 1.5   
  
omega-3 
(g) 0.01 0.02     
Raspberry Bran Muffin 







Carb (g)   
15 27 dairy and nuts 
1 cup yogurt 
Fibre (g)     
2 2   
  Protein (g) 3 11   
  Fat (g) 6 14   
  
omega-3 
(g) 0.72 0.79     
Blueberry Smoothie 
Kcal   
60 260 Dairy 
Traces of 
wheat 
(Take 1/2 cup=1 portion) Carb (g)   14 15   
50 g cheese Fibre (g)     2 2   
  Protein (g) 1 13   
  Fat (g) 0 17   
  
omega-3 
(g) 0 0.18     
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Banana muffin (1 muffin) Kcal   152 301 
 
 
1 cup yogurt Carb (g)   22 33 Wheat, eggs 
Traces of 
soy, nuts 
  Fibre (g)     3 3   
  Protein (g) 3 12   




































(take 2 pieces = 2 
portions) 
Grain Carb (g)   26 63 
  F/V 
Fibre 
(g)     
5 10 




   Fat (g) 6 20 





chicken stir fry & 
Lentil rice recipe  
Ok as is 
Mt/alt Kcal   455 455 
none wheat 
(take ¾ cup 
chicken breast + 1 
cup frozen veggies 
+ ¾ cup rice and 
lentils) 
Grain Carb (g)   75 75 
  F/V 
Fibre 









Fat (g) 2.5 2.5 




Hummus Mt/alt Kcal   70 542 Sesame, milk none 
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wheat pita  







(g)     
1 6 




     Fat (g) 3.5 26 





with navy beans  
Ok as is 








(take 1 cup = 2 
portions) 
Grain Carb (g)   27 54 
  F/V 
Fibre 









Fat (g) 4 8 










Mt/alt Kcal   140 621 
none wheat 
(take 2 cups = 2 
portions) 
50 g cheese Grain Carb (g)   25 72 
    F/V 
Fibre 
(g)     
5 14 




     Fat (g) 2.5 23 





#3 Breakfast Recipes / 
Items 
Key nutrition facts   Allergens 
per portion (recipes) 
per 
meal 
CONTAINS: MAY CONTAIN: 
Cinnamon Oatmeal 
with 1 Tablespoon 
Kcal   
100 137 
 Traces of wheat, 
nuts, soy 
  59 
ground flaxseed (1/2 
cup ~125 ml) 
Carb 









n (g) 3 5 
  





1.64 1.64     
Kasha granola bar 
Kcal   
160 190 Egg, dairy 




(g)   27 34   
  
Fibre 
(g)     4 5   
  
Protei
n (g) 5 6   
  Fat (g) 4 4   
  
omega
-3 (g) 0.49 0.49     
Pumpkin muffin 
Kcal   
160 218 Wheat, eggs 




(g)   21 36   
1 fruit of your choice 
Fibre 
(g)     2 5   
  
Protei
n (g) 3 4   
  Fat (g) 7 8   
  
omega
-3 (g) 1.15 1.15     
Apple Cinammon 
breakfast risotto 
Kcal   
130 400 Dairy 
Traces of wheat, 
nuts, soy 
(take 1 cup - 2 
portions) 
Carb 
(g)   28 67.5   
1 cup yogurt 
Fibre 
(g)     2 3   
  
Protei
n (g) 2 12   
  Fat (g) 1 10   
  
omega
-3 (g) 0.06 0.19     
Cornbread muffin Kcal   100 358 Wheat, eggs Traces of 
1 muffin 
Carb 
(g)   
20 35 dairy soy and nuts 
50 g cheese 
Fibre 
(g)     
2 2 
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apricot chicken & 
Lentil rice recipe             
(take 1 piece 
chicken + 1/2 cup 
apricot sauce + ¾ 
cup rice and lentils) 
baby carrots 





















Ok as is 













(g)   
54 69.45 
  F/V 
Fibre 
(g)     
4.54 6.88 




   Fat (g) 11.24 11.4 





chickpea curry & 
Lemon rice (take 
¾ cup curry + 2/3 
cup rice)  
1 apple 
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Black bean burrito 
farce (take 1 cup) 
Tortilla (10" 
or 70 g) or 2 
slices whole 
grain bread 




























Mt/alt Kcal   160 330 
none none 
(take 1 cup) Grain 
Carb 
(g)   
29 64 
  F/V 
Fibre 









Fat (g) 2.5 4.5 





#4 Breakfast Recipes / 
Items 
Key nutrition facts   Allergens 
per portion (recipes) 
per 
meal 
CONTAINS: MAY CONTAIN: 
Cranberry-orange rice 
pudding 
Kcal   
120 312 Dairy 
Traces of wheat 
soy 
(Take 1 cup=2 portions) 
Carb (g)   
25 69  and nuts 
1 Apple Fibre (g)     0 3   
  Protein (g) 4 8   
  Fat (g) 0.5 1.5   
  
omega-3 
(g) 0.01 0.02     
Raspberry Bran Muffin 




Traces of wheat, 
soy 
Take 1portion Carb (g)   15 27   
1 cup yogurt Fibre (g)     2 2   
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  Protein (g) 3 11   
  Fat (g) 6 14   
  
omega-3 
(g) 0.72 0.79     
Blueberry Smoothie 
Kcal   
60 260 Dairy Traces of wheat 
(Take 1/2 cup=1 
portion) 
Carb (g)   
14 15   
50 g cheese Fibre (g)     2 2   
  Protein (g) 1 13   
  Fat (g) 0 17   
  
omega-3 
(g) 0 0.18     
Banana muffin (1 
muffin) 
Kcal   152 301 
 
 
1 cup yogurt Carb (g)   22 33 Wheat, eggs Traces of soy, nuts 
  Fibre (g)     3 3   
  Protein (g) 3 12   




0.34 0.41     
Orange spice zucchini 
muffins  (take 1 muffins 
= 1 portion) 50 g of 
cheese 
Kcal   140 339 
Wheat, 
eggs,  
Traces of soy, 
nuts 
Carb (g)   18 18 dairy  
Fibre (g)     2 2   
Protein (g) 3 16   


























Wheat berry and 
apple salad (take 
2 portions of  ¾ 




Grain Kcal   100 350 
Wheat Sulphites 
F/V Carb (g)   17 45 
Milk/al
t 




 Fat (g) 4 19 



















Grain Carb (g)   32 43 






 Fat (g) 7 15 




zucchini muffins  
















Grain Carb (g)   18 56 







   Fat (g) 6 27 




South East Asian 
inspired salmon 
and rice cakes 
(take 2 patties) 
Green salad, 
glass of milk 
Mt/alt Kcal   360 460 
Fish, eggs   Grain 
Carb (g)   19 31 
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Fat (g) 17 19 
  omega-3 
(g) 
2.07 2.08 
Pinto bean soup 

















Grain Carb (g)   34 52 






 Fat (g) 3 23 
  omega-3 
(g) 
0.25 0.41 
#5 Breakfast Recipes 
/ Items 
Key nutrition facts   Allergens 
per portion (recipes) 
per 
meal 
CONTAINS: MAY CONTAIN: 
Cinnamon Oatmeal 
with 1 Tablespoon 
ground flaxseed (1/2 
cup ~125 ml) 
Kcal   
100 137 
 
Traces of wheat, 
nuts, soy 
Carb (g)   
17 19 
  
  Fibre (g)     3 5   
  Protein (g) 3 5   




1.64 1.64     
Kasha granola bar 
Kcal   
160 190 Egg, dairy 
Traces of wheat, 
nuts, soy 
1 Plum Carb (g)   27 34   
  Fibre (g)     4 5   
  Protein (g) 5 6   
  Fat (g) 4 4   
  
omega-3 
(g) 0.49 0.49     
Pumpkin muffin 
Kcal   
160 218 Wheat, eggs 
Traces of wheat, 
nuts, soy 
(1 muffin) Carb (g)   21 36   
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1 fruit of your choice Fibre (g)     2 5   
  
Protein (g) 
3 4   
  Fat (g) 7 8   
  
omega-3 
(g) 1.15 1.15     
Apple Cinammon 
breakfast risotto 
(take 1 cup - 2 
portions), 1 cup 
yogurt 
Kcal   
130 400 Dairy 
Traces of wheat, 
nuts, soy 
Carb (g)   28 67.5   
Fibre (g)     2 3   
Protein (g) 2 12   
Fat (g) 1 10   
omega-3 
(g) 0.06 0.19     
Cornbread muffin Kcal   100 358 Wheat, eggs Traces of 
1 muffin Carb (g)   20 35 dairy soy and nuts 
50 g cheese Fibre (g)     2 2   
125 ml grapes 
(seedless) 
Protein (g) 3 16 
  























Lentil & BBQ 




rice or bread 
Mt/alt Kcal   260 496 
none 
Sulphites, 
nuts, soy or 
sesame   
(take 1 cup) 




(g)   
42 67 
    F/V 
Fibre 
(g)     
7 9 




     Fat (g) 9 18 


















(take 1 cup potato + 
1 piece chicken) 
Grain 
Carb 
(g)   
22 46 
  F/V 
Fibre 
(g)     
2.5 7.5 




   Fat (g) 10 10 




Spinach tofu dip 





Mt/alt Kcal   15 297   
(take 1/3 cup = 
approx. 3 portions) 
Grain 
Carb 


















     Fat (g) 1 12 
  








& Lemon rice 
(take ¾ cup curry 
+ 2/3 cup rice) 
Ok as is 



















soup with lentils 
Whole grain 
bread, 1 slice 
Mt/alt Kcal   140 549 
none wheat 
(take 2 cups = 2 
portions) 
50 g cheese Grain 
Carb 
(g)   
25 61 
    F/V 
Fibre 
(g)     
5 12 




     Fat (g) 2.5 23 
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#6 Breakfast Recipes / 
Items 
Key nutrition facts   Allergens 
per portion (recipes) 
per 
meal 
CONTAINS: MAY CONTAIN: 
Raspberry Bran Muffin 
Kcal   
120 272 
Wheat, 
eggs Traces of wheat, soy 
Take 1portion 
Carb (g)   
15 27 
  
1 cup yogurt Fibre (g)     2 2   
  
Protein 
(g) 3 11 
  
  Fat (g) 6 14   
  
omega-3 
(g) 0.72 0.79     
Cranberry-orange rice 
pudding 
Kcal   
120 312 Dairy Traces of wheat soy 
(Take 1 cup=2 portions) 
Carb (g)   
25 69  and nuts 
1 Apple Fibre (g)     0 3   
  
Protein 
(g) 4 8   
  Fat (g) 0.5 1.5   
  
omega-3 
(g) 0.01 0.02     
Blueberry Smoothie Kcal   60 260   
(Take 1/2 cup=1 
portion) 
Carb (g)   
14 15   
50 g cheese Fibre (g)     2 2   
  
Protein 
(g) 1 13   
  Fat (g) 0 17   
  
omega-3 
(g) 0 0.18     
Banana muffin (1 
muffin) 
Kcal   152 301 
 
 
1 cup yogurt Carb (g)   22 33 
Wheat, 
eggs 
Traces of soy, nuts 










0.34 0.41     
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Cinnamon Oatmeal 
with 1 Tablespoon 
ground flaxseed (1/2 
cup ~125 ml) 
Kcal   
100 137  
Traces of wheat, nuts, 
soy 
Carb (g)   17 19   
  Fibre (g)     3 5   
  
Protein 
(g) 3 5   























Quinoa Salad  
250 mL milk or 
kefir, orange 
slices 
 Kcal   210 580 
none Wheat, sulfites 
(take 2 portions of  
¾ cup = 1 ½ cups) 
Grain Carb (g)   39 106 
  F/V Fibre (g)     5 12 




   Fat (g) 2.5 8 





potato cakes  
Fresh garden 
salad 






(take 2 patties) 
250 mL milk or 
yogurt 
F/V Carb (g)   15 56 
    Milk/alt Fibre (g)     2 7 





    
 
Fat (g) 4 19 








250mL milk or 
yogurt 
Mt/alt Kcal   240 463   
(take ¾ cup = 1 
piece) 
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Fat (g) 11 13 
  
    
omega-
3 (g) 











(take 1 cup mole +   
2/3 cup rice) 
250 mL milk or 
yogurt 
Grain Carb (g)   46 83 
    Milk/alt Fibre (g)     10 15 




     Fat (g) 6 9 






with lentils   
15 low sodium 
rice crackers  
Mt/alt Kcal   160 340 
none none 
(take 1 cup) Grain Carb (g)   28 65 








Fat (g) 3 5 





Appendix C : Breakdown of nutrients contents and average calories  
Breakdown of nutrient contents 
AVERAGE  Kcal Carb (g)   Fibre (g)     Protein (g) Fat (g) 
omega-3 
(g) 
breakfast meals 249   38 4 8   8 0.78 
lunch meals 491   66 9 23  15 0.27 








Week 1 249 38 4 8 8 0.78 
Week 2 301 36 2 12 13 0.32 
Week 3  261 38 4 9 9 0.74 
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Week 4 297 32 2 12 14 0.38 
Week 5 261 38 4 9 9 0.74 
Week 6 256 33 3 10 10 0.61 
TOTAL 270.8333333 35.83333333 3.166666667 10 10.5 0.718333333 




      
AVERAGE 
LUNCH 




Week 1 491 66 9 23 15 0.27 
Week 2 491 61.2 9.8 25 15.9 0.72 
Week 3 371 56.59 11.3 14.9 6.7 0.68 
Week 4 439.4 45.4 5.6 22 20.6 0.78 
Week 5 404.4 51.55 7.9 21.3 14.16 0.86 
Week 6 480.4 73.8 9.8 24 10.8 0.516 
TOTAL  446.2 59.09 8.9 21.7 13.86 0.637666667 
 
 
       
       




Week 1 740 104 13 31 23 1.05 
Week 2 792 97 12 37 29 1 
Week 3 632 95 15 24 16 1 
Week 4 736 78 8 34 35 1 
Week 5 665 90 12 30 23 2 
Week 6 737 106 13 34 21 1.1 
TOTAL  717 95 12.16666667 31.66666667 24.5 1.191666667 
 
